EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The microbiome-immune cell interaction network: Advancing tumor immunotherapy

Wei Liu, Zhou Lan, Zhenzi Lin, Yuyue Zhao, Junxiang Lian, Guangtao Yu

Seminars in Cancer Biology · 2025-09 · 114 · 128-137

DOI: 10.1016/j.semcancer.2025.06.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-09. Verfasst von Wei Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, 510280, China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Microbiota. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immunotherapy has achieved revolutionary advancements; however, owing to the complex interplay of multiple intrinsic and extrinsic tumor factors, the patient response rate remains suboptimal. Recent research has emphasized the pivotal role of microbiome in tumor progression. Under normal physiological conditions, microbiome enter orally and colonize sites such as the oral and intestinal mucosa, establishing a dynamic microbiome equilibrium that participates in essential physiological processes, including host metabolism and immune regulation. However, in pathological states, including dysbiosis, tumor initiation, or compromised mucosal barrier function, the microbiome can penetrate the mucosal barrier, infiltrate tumor tissues, and engage in intricate direct or indirect interactions with immune cells. These interactions play a pivotal role in reshaping the tumor immune microenvironment and modulating the host's anti-tumor immune response. This review elaborate the regulatory mechanisms involved in direct and indirect interactions between microbiome and immune cells within tumors, and their implications for tumor immunotherapy. We discuss the external factors that impact these interactions and outline the potential use of engineered bacteria in cancer treatment. From the perspective of the interaction network between microbiomes and immune cells, this review elucidates the mechanisms and potential of microbiomes in tumor immunotherapy, offering new insights and potential targets for innovative strategies in tumor prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyMicrobiotaHumansTumor MicroenvironmentAnimalsGastrointestinal MicrobiomeDysbiosis

Stichwörter der Autor:innen

Engineered bacteriaImmune interactionsMicrobiomeTumor immunotherapy

Autor:innen und Institutionen

  • Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, 510280, China.
  • Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, 510280, China. Electronic address: guangtao1986@smu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Liu, W., Lan, Z., Lin, Z., Zhao, Y., Lian, J., & Yu, G. (2025). The microbiome-immune cell interaction network: Advancing tumor immunotherapy. Seminars in Cancer Biology, 114, 128-137. https://doi.org/10.1016/j.semcancer.2025.06.009

Vancouver

Liu W, Lan Z, Lin Z, Zhao Y, Lian J, Yu G. The microbiome-immune cell interaction network: Advancing tumor immunotherapy. Seminars in Cancer Biology. 2025;114:128-137. doi:10.1016/j.semcancer.2025.06.009

BibTeX
@article{Liu2025,
  author = {Liu, Wei and Lan, Zhou and Lin, Zhenzi and Zhao, Yuyue and Lian, Junxiang and Yu, Guangtao},
  title = {The microbiome-immune cell interaction network: Advancing tumor immunotherapy},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  volume = {114},
  pages = {128--137},
  doi = {10.1016/j.semcancer.2025.06.009}
}
Kostenlos starten →